• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (241)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Psychiatry  • Cognitive Therapy  • Alert me on articles by topic  Social Bookmarking   What's this?

Robert J. DeRubeis, PhD; Steven D. Hollon, PhD; Jay D. Amsterdam, MD; Richard C. Shelton, MD; Paula R. Young, PhD; Ronald M. Salomon, MD; John P. O’Reardon, MD; Margaret L. Lovett, MEd; Madeline M. Gladis, PhD; Laurel L. Brown, PhD; Robert Gallop, PhD

Arch Gen Psychiatry. 2005;62:409-416.

Background  There is substantial evidence that antidepressant medications treat moderate to severe depression effectively, but there is less data on cognitive therapy’s effects in this population.

Objective  To compare the efficacy in moderate to severe depression of antidepressant medications with cognitive therapy in a placebo-controlled trial.

Design  Random assignment to one of the following: 16 weeks of medications (n = 120), 16 weeks of cognitive therapy (n = 60), or 8 weeks of pill placebo (n = 60).

Setting  Research clinics at the University of Pennsylvania, Philadelphia, and Vanderbilt University, Nashville, Tenn.

Patients  Two hundred forty outpatients, aged 18 to 70 years, with moderate to severe major depressive disorder.

Interventions  Some study subjects received paroxetine, up to 50 mg daily, augmented by lithium carbonate or desipramine hydrochloride if necessary; others received individual cognitive therapy.

Main Outcome Measure  The Hamilton Depression Rating Scale provided continuous severity scores and allowed for designations of response and remission.

Results  At 8 weeks, response rates in medications (50%) and cognitive therapy (43%) groups were both superior to the placebo (25%) group. Analyses based on continuous scores at 8 weeks indicated an advantage for each of the active treatments over placebo, each with a medium effect size. The advantage was significant for medication relative to placebo, and at the level of a nonsignificant trend for cognitive therapy relative to placebo. At 16 weeks, response rates were 58% in each of the active conditions; remission rates were 46% for medication, 40% for cognitive therapy. Follow-up tests of a site x treatment interaction indicated a significant difference only at Vanderbilt University, where medications were superior to cognitive therapy. Site differences in patient characteristics and in the relative experience levels of the cognitive therapists each appear to have contributed to this interaction.

Conclusion  Cognitive therapy can be as effective as medications for the initial treatment of moderate to severe major depression, but this degree of effectiveness may depend on a high level of therapist experience or expertise.

Author Affiliations: Departments of Psychology (Dr DeRubeis), and Psychiatry (Drs Amsterdam, Young, O’Reardon, and Gladis), University of Pennsylvania, Philadelphia; Departments of Psychology (Dr Hollon), and Psychiatry (Drs Shelton, Salomon, Lovett, and Brown), Vanderbilt University, Nashville, Tenn; Department of Mathematics and Applied Statistics, West Chester University, West Chester, Pa (Dr Gallop).

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Prevention of Relapse Following Cognitive Therapy vs Medications in Moderate to Severe Depression
Steven D. Hollon, Robert J. DeRubeis, Richard C. Shelton, Jay D. Amsterdam, Ronald M. Salomon, John P. O’Reardon, Margaret L. Lovett, Paula R. Young, Kirsten L. Haman, Brent B. Freeman, and Robert Gallop
Arch Gen Psychiatry. 2005;62(4):417-422.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Severity of depression and response to antidepressants: GENPOD randomised controlled trial
Wiles et al.
Br. J. Psychiatry 2012;200:130-136.
ABSTRACT | FULL TEXT  

Distinct but overlapping neural networks subserve depression and insecure attachment
Galynker et al.
Soc Cogn Affect Neurosci 2011;0:nsr074v1-nsr074.
ABSTRACT | FULL TEXT  

Behavioral Activation for the Treatment of Atypical Depression: A Pilot Open Trial
Weinstock et al.
Behav Modif 2011;35:403-424.
ABSTRACT  

Usual and Unusual Care: Existing Practice Control Groups in Randomized Controlled Trials of Behavioral Interventions
Freedland et al.
Psychosom. Med. 2011;73:323-335.
ABSTRACT | FULL TEXT  

Men and depression
Ogrodniczuk and Oliffe
cfp 2011;57:153-155.
FULL TEXT  

Les hommes et la depression
Ogrodniczuk and Oliffe
cfp 2011;57:e39-e41.
FULL TEXT  

Acute and Sustained Effects of Cognitive Emotion Regulation in Major Depression
Erk et al.
J. Neurosci. 2010;30:15726-15734.
ABSTRACT | FULL TEXT  

Open Trial of Vinyasa Yoga for Persistently Depressed Individuals: Evidence of Feasibility and Acceptability
Uebelacker et al.
Behav Modif 2010;34:247-264.
ABSTRACT  

What underlies the perception that a medical intervention is effective? An exploratory study among smokers
Vogt et al.
Nicotine Tob Res 2010;12:508-515.
ABSTRACT | FULL TEXT  

Antidepressant Drug Effects and Depression Severity: A Patient-Level Meta-analysis
Fournier et al.
JAMA 2010;303:47-53.
ABSTRACT | FULL TEXT  

Chapter 9 Psychotherapy
McIntyre and Nathanson
OPL Severe Depression 2010;1:med-9780199570249-chapter-med-9780199570249-chapter.
ABSTRACT | FULL TEXT  

Mental Disorder, Predisposition, Prediction, and Ability to Control: Evaluating Sex Offenders for Civil Commitment
Elwood
Sex Abuse 2009;21:395-411.
ABSTRACT  

Personality Change During Depression Treatment: A Placebo-Controlled Trial
Tang et al.
Arch Gen Psychiatry 2009;66:1322-1330.
ABSTRACT | FULL TEXT  

Clinical effectiveness of online computerised cognitive-behavioural therapy without support for depression in primary care: randomised trial
de Graaf et al.
Br. J. Psychiatry 2009;195:73-80.
ABSTRACT | FULL TEXT  

Treatment of Depression After Coronary Artery Bypass Surgery: A Randomized Controlled Trial
Freedland et al.
Arch Gen Psychiatry 2009;66:387-396.
ABSTRACT | FULL TEXT  

The Cognitive and Affective Structure of Paranoid Delusions: A Transdiagnostic Investigation of Patients With Schizophrenia Spectrum Disorders and Depression
Bentall et al.
Arch Gen Psychiatry 2009;66:236-247.
ABSTRACT | FULL TEXT  

Men and Therapy: A Case of Masked Male Depression
Rabinowitz and Cochran
Clinical Case Studies 2008;7:575-591.
ABSTRACT  

Current Status and Future Prospects of Clinical Psychology: Toward a Scientifically Principled Approach to Mental and Behavioral Health Care
Baker et al.
Psychological Science in the Public Interest 2008;9:67-103.
ABSTRACT | FULL TEXT  

Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines
Anderson et al.
J Psychopharmacol 2008;22:343-396.
ABSTRACT  

Antidepressant medications v. cognitive therapy in people with depression with or without personality disorder
Fournier et al.
Br. J. Psychiatry 2008;192:124-129.
ABSTRACT | FULL TEXT  

Uncritical positive regard? Issues in the efficacy and safety of psychotherapy
Nutt and Sharpe
J Psychopharmacol 2008;22:3-6.
 

Psychological approach to managing irritable bowel syndrome
Hayee and Forgacs
BMJ 2007;334:1105-1109.
FULL TEXT  

Utility of Observer-Rated and Self-Report Instruments for Detecting Major Depression in Women After Cardiac Surgery: A Pilot Study
Doering et al.
Am J Crit Care 2007;16:260-269.
ABSTRACT | FULL TEXT  

Effects of Citalopram and Interpersonal Psychotherapy on Depression in Patients With Coronary Artery Disease: The Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) Trial
Lesperance et al.
JAMA 2007;297:367-379.
ABSTRACT | FULL TEXT  

Three decades of antidepressant, anxiolytic and hypnotic use in a national population birth cohort
Colman et al.
Br. J. Psychiatry 2006;189:156-160.
ABSTRACT | FULL TEXT  

Depression and cardiovascular disease: healing the broken-hearted.
Whooley
JAMA 2006;295:2874-2881.
ABSTRACT | FULL TEXT  

Enhancing the efficacy of antidepressants with psychotherapy
Petersen
J Psychopharmacol 2006;20:19-28.
ABSTRACT  

Neurobiological Mechanisms of the Placebo Effect
Benedetti et al.
J. Neurosci. 2005;25:10390-10402.
FULL TEXT  

Other articles noted
Evid. Based Ment. Health 2005;8:94-94.
FULL TEXT  

The Current State of Cognitive Therapy: A 40-Year Retrospective
Beck
Arch Gen Psychiatry 2005;62:953-959.
ABSTRACT | FULL TEXT  

Cognitive Therapy Versus Antidepressants for More Severe Depressions
JWatch Psychiatry 2005;2005:3-3.
FULL TEXT  

Depression Treatment: What Works? For How Long?
JWatch Women's Health 2005;2005:7-7.
FULL TEXT  

Prevention of Relapse Following Cognitive Therapy vs Medications in Moderate to Severe Depression
Hollon et al.
Arch Gen Psychiatry 2005;62:417-422.
ABSTRACT | FULL TEXT